These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

860 related items for PubMed ID: 23094720

  • 1. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
    Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS.
    N Engl J Med; 2012 Oct 25; 367(17):1587-95. PubMed ID: 23094720
    [Abstract] [Full Text] [Related]

  • 2. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
    Raatikainen MJ, Hakalahti A, Uusimaa P, Nielsen JC, Johannessen A, Hindricks G, Walfridsson H, Pehrson S, Englund A, Hartikainen J, Kongstad O, Mortensen LS, Hansen PS, MANTRA-PAF investigators.
    Int J Cardiol; 2015 Nov 01; 198():108-14. PubMed ID: 26163901
    [Abstract] [Full Text] [Related]

  • 3. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
    Walfridsson H, Walfridsson U, Nielsen JC, Johannessen A, Raatikainen P, Janzon M, Levin LA, Aronsson M, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS.
    Europace; 2015 Feb 01; 17(2):215-21. PubMed ID: 25567068
    [Abstract] [Full Text] [Related]

  • 4. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.
    Pappone C, Vicedomini G, Augello G, Manguso F, Saviano M, Baldi M, Petretta A, Giannelli L, Calovic Z, Guluta V, Tavazzi L, Santinelli V.
    Circ Arrhythm Electrophysiol; 2011 Dec 01; 4(6):808-14. PubMed ID: 21946315
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2340-7. PubMed ID: 17161267
    [Abstract] [Full Text] [Related]

  • 6. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R, Alboni P, Bruna C, Vincenti A, Verlato R, PAF 2 Study Investigators.
    Eur Heart J; 2002 Jun 05; 23(11):892-900. PubMed ID: 12042011
    [Abstract] [Full Text] [Related]

  • 7. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
    Pokushalov E, Romanov A, De Melis M, Artyomenko S, Baranova V, Losik D, Bairamova S, Karaskov A, Mittal S, Steinberg JS.
    Circ Arrhythm Electrophysiol; 2013 Aug 05; 6(4):754-60. PubMed ID: 23748210
    [Abstract] [Full Text] [Related]

  • 8. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P, Polańska M, Chojnowska L, Michałowska I, Wójcik A, Piotrowicz E, Lech A, Kłopotowski M, Baranowski R, Przybylski A, Bilińska M, Sierpiński R, Walczak F, Szumowski L.
    Kardiol Pol; 2013 Aug 05; 71(1):17-24. PubMed ID: 23348529
    [Abstract] [Full Text] [Related]

  • 9. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.
    Schumacher B, Jung W, Lewalter T, Vahlhaus C, Wolpert C, Lüderitz B.
    Am J Cardiol; 1999 Mar 01; 83(5):710-3. PubMed ID: 10080423
    [Abstract] [Full Text] [Related]

  • 10. [Long-term follow-up of right atrial multilinear high-frequency ablation in the treatment of recurrent paroxysmal atrial fibrillation].
    Dierkes S, Hennersdorf MG, Vester EG, Perings C.
    Dtsch Med Wochenschr; 2003 Jan 24; 128(4):130-4. PubMed ID: 12589581
    [Abstract] [Full Text] [Related]

  • 11. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.
    Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN, STOP AF Cryoablation Investigators.
    J Am Coll Cardiol; 2013 Apr 23; 61(16):1713-23. PubMed ID: 23500312
    [Abstract] [Full Text] [Related]

  • 12. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
    Aronsson M, Walfridsson H, Janzon M, Walfridsson U, Nielsen JC, Hansen PS, Johannessen A, Raatikainen P, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Levin LÅ.
    Europace; 2015 Jan 23; 17(1):48-55. PubMed ID: 25341739
    [Abstract] [Full Text] [Related]

  • 13. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
    Nielsen JC, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Pehrson SM, Englund A, Hartikainen J, Mortensen LS, Hansen PS, MANTRA-PAF Investigators.
    Heart; 2017 Mar 23; 103(5):368-376. PubMed ID: 27566295
    [Abstract] [Full Text] [Related]

  • 14. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.
    Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, Roux JF, Yung D, Skanes A, Khaykin Y, Morillo C, Jolly U, Novak P, Lockwood E, Amit G, Angaran P, Sapp J, Wardell S, Lauck S, Macle L, Verma A, EARLY-AF Investigators.
    N Engl J Med; 2021 Jan 28; 384(4):305-315. PubMed ID: 33197159
    [Abstract] [Full Text] [Related]

  • 15. Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study.
    Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Turov A, Shirokova N, Karaskov A.
    Circ Arrhythm Electrophysiol; 2011 Dec 28; 4(6):823-31. PubMed ID: 21930653
    [Abstract] [Full Text] [Related]

  • 16. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM, Verma A, Talajic M, Nattel S, Dorian P, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Dec 28; 27(1):47-59. PubMed ID: 21329862
    [Abstract] [Full Text] [Related]

  • 17. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
    Poole JE, Bahnson TD, Monahan KH, Johnson G, Rostami H, Silverstein AP, Al-Khalidi HR, Rosenberg Y, Mark DB, Lee KL, Packer DL, CABANA Investigators and ECG Rhythm Core Lab.
    J Am Coll Cardiol; 2020 Jun 30; 75(25):3105-3118. PubMed ID: 32586583
    [Abstract] [Full Text] [Related]

  • 18. Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation.
    Pokushalov E, Romanov A, Artyomenko S, Baranova V, Losik D, Bairamova S, Karaskov A, Mittal S, Steinberg JS.
    J Cardiovasc Electrophysiol; 2013 Mar 30; 24(3):274-9. PubMed ID: 23210695
    [Abstract] [Full Text] [Related]

  • 19. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).
    Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, Turco P, Pascotto P, Fazzari M, Vitale DF.
    Eur Heart J; 2006 Jan 30; 27(2):216-21. PubMed ID: 16214831
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E, Denjoy I.
    Am J Cardiol; 1996 Jan 25; 77(3):66A-71A. PubMed ID: 8607394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.